Rosiglitazone for HIV-1 lipoatrophy

Rodrigo B. Cavalcanti(University of Toronto), Sharon Walmsley(University Health Network), Kevin C. Kain(University of Toronto), Janet Raboud(University Health Network)
The Lancet
May 1, 2004
Cited by 3


Related Papers